27 September 2023 · The availability of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD) varies currently. Supply content is maintained regularly by DHSC.
14 October 2022 · Constipation in people taking clozapine can be fatal. Guidance on preventing and managing constipation in these individuals is described.
17 February 2023 · Prior response, side-effects, new contraindications, and current depression symptoms may require switching antidepressants. When it is, establish shared goals.
17 February 2023 · Review people at appropriate time points; advise on what to expect and report; and beware of the possibility of discontinuation and serotonin syndromes.
13 January 2023 · Paroxetine and sertraline are the Selective Serotonin Reuptake Inhibitors (SSRIs) of choice. Recommendations apply to full term and healthy infants only.
31 May 2023 · Guidance on clozapine administration including crushing tablets, importance of not missing doses and practical considerations regarding switching formulations
4 December 2023 · Deprescribing antidepressants involves safely reducing and withdrawing them. An introduction; signposting to current resources; and SPS resources coming soon.
16 November 2023 · Support for the system in continuing to manage supply disruption of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD).
15 February 2024 · Lorazepam and oxazepam are the preferred benzodiazepines during breast feeding, if clinically appropriate. Recommendations apply to full term, healthy infants.
19 September 2023 · Speakers shared experiences of supporting people living with mental health conditions to show that you don’t have to be an expert to make a contribution